Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 1.00 |
| ▸ | PPARD | Q03181 | 6/20 | 1.00 |
| ▸ | PPARA | Q07869 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | FABP4 | P15090 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | NR4A2 | P43354 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | BLM | P54132 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | AKR1C3 | P42330 | 2/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Arachidonic Acid SCHEMBL16162 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL18185389 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL18185506 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| SCHEMBL542241 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL12288820 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL25417373 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL18185485 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL3064930 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL20656587 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL17798896 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026041693-A1 | HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS | SPSV B.V. (NL) | 2026-02-26 | — | — | WO | claimed |
| EP-4700098-A1 | HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS | SPSV B.V. (NL) | 2026-02-25 | — | — | EP | claimed |
| WO-2025235978-A1 | SYSTEMS AND METHODS FOR STABLE CELLULAR MEDIA | MEMBRANE PROTECTIVE TECHNOLOGIES, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250304916-A1 | METHODS AND COMPOSITIONS FOR GENERATING VASCULAR LEPTOMENINGEAL CELLS | TRAILHEAD BIOSYSTEMS INC (US) | 2025-10-02 | — | — | US | claimed |
| US-20250195352-A1 | LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND OTHER BIOACTIVE AGENTS | SCIADONICS, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250099553-A1 | COMPOSITION AND METHODS FOR MODULATION OF ELOVL2 | YOUHEALTH BIOTECH, LIMITED (KY) | 2025-03-27 | — | — | US | claimed |
| WO-2023172718-A1 | LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND OTHER BIOACTIVE AGENTS | SCIADONICS, INC. (US) | 2023-09-14 | — | — | WO | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-112679343-B | Method for preparing high-purity ethyl pinocerate by utilizing torreya grandis seed oil | 浙江工业大学 | 2022-11-25 | — | — | CN | claimed |
| CN-112996500-A | Compositions and methods for modulating ELOVL2 | 优美佳生物技术有限公司 | 2021-06-18 | — | — | CN | claimed |
| US-20170027902-A1 | Use of a Composition Comprising a Flavonol, A Flavonoid, and a Fatty Acid in the Treatment of Oxidative Injuries Due to Mitochondrial Dysfunction | ROBERTSON, GEORGE (CA) | 2017-02-02 | — | — | US | claimed |
| WO-2015154192-A1 | USE OF A COMPOSITION COMPRISING A FLAVONOL, A FLAVONOID, AND A FATTY ACID IN THE TREATMENT OF OXIDATIVE INJURIES DUE TO MITOCHONDRIAL DYSFUNCTION | ROBERTSON GEORGE (CA) | 2015-10-15 | — | — | WO | claimed |
| EP-4739649-A1 | MODIFIED BIO-BASED REACTIVE MONOMER CONTAINING COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Soprema, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| WO-2026041693-A1 | HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS | SPSV B.V. (NL) | 2026-02-26 | — | — | WO | disclosed |
| EP-4700098-A1 | HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS | SPSV B.V. (NL) | 2026-02-25 | — | — | EP | disclosed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| EP-2035573-B1 | METHODS FOR IDENTIFYING MODULATORS OF EOXIN FORMATION | BIOLIPOX AB (SE) | 2010-08-18 | — | — | EP | disclosed |
| WO-2010020678-A1 | MOISTURE-CURING, WATER-RESISTANT COATING COMPOSITION, COMPRISING A POLYMER HAVING REACTIVE SILYL GROUPS | HENKEL AG & CO. KGAA (DE) | 2010-02-25 | — | — | WO | disclosed |
| WO-2009133061-A1 | HARDENABLE COMPOSITIONS BASED ON SILYLATED POLYURETHANE | HENKEL AG & CO. KGAA (DE) | 2009-11-05 | — | — | WO | disclosed |
| WO-2009133062-A1 | HARDENABLE COMPOSITIONS BASED ON SILYLATED POLYURETHANES | HENKEL AG & CO. KGAA (DE) | 2009-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250195352-A1 | LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND OTHER BIOACTIVE AGENTS | SGMS2, ALOX12, ALOX15 | PPARG 262/4885PPARD 1225/4885PPARA 367/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | PPARG 872/4885PPARD 260/4885PPARA 517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.